Functional isogenic modeling of BRCA1 alleles reveals distinct carrier phenotypes

Rory L. Cochran, Justin Cidado, Minsoo Kim, Daniel J. Zabransky, Sarah Croessmann, David Chu, Hong Yuen Wong, Julia Beaver, Karen Cravero, Bracha Erlanger, Heather Parsons, Christopher M Heaphy, Alan Keith Meeker, Josh Lauring, Ben Ho Park

Research output: Contribution to journalArticle

Abstract

Clinical genetic testing of BRCA1 and BRCA2 is commonly performed to identify specific individuals at risk for breast and ovarian cancers who may benefit from prophylactic therapeutic interventions. Unfortunately, it is evident that deleterious BRCA1 alleles demonstrate variable penetrance and that many BRCA1 variants of unknown significance (VUS) exist. In order to further refine hereditary risks that may be associated with specific BRCA1 alleles, we performed gene targeting to establish an isogenic panel of immortalized human breast epithelial cells harboring eight clinically relevant BRCA1 alleles. Interestingly, BRCA1 mutations and VUS had distinct, quantifiable phenotypes relative to isogenic parental BRCA1 wild type cells and controls. Heterozygous cells with known deleterious BRCA1 mutations (185delAG, C61G and R71G) demonstrated consistent phenotypes in radiation sensitivity and genomic instability assays, but showed variability in other assays. Heterozygous BRCA1 VUS cells also demonstrated assay variability, with some VUS demonstrating phenotypes more consistent with deleterious alleles. Taken together, our data suggest that BRCA1 deleterious mutations and VUS can differ in their range of tested phenotypes, suggesting they might impart varying degrees of risk. These results demonstrate that functional isogenic modeling of BRCA1 alleles could aid in classifying BRCA1 mutations and VUS, and determining BRCA allele cancer risk.

Original languageEnglish (US)
Pages (from-to)25240-25251
Number of pages12
JournalOncotarget
Volume6
Issue number28
DOIs
StatePublished - 2015

Fingerprint

Alleles
Phenotype
Mutation
Gene Targeting
Penetrance
Genomic Instability
Radiation Tolerance
Genetic Testing
Ovarian Neoplasms
Breast
Epithelial Cells
Breast Neoplasms
Neoplasms
Therapeutics

Keywords

  • BRCA1
  • Breast cancer
  • Centrosome amplification
  • Haploinsufficiency
  • VUS

ASJC Scopus subject areas

  • Oncology

Cite this

Cochran, R. L., Cidado, J., Kim, M., Zabransky, D. J., Croessmann, S., Chu, D., ... Park, B. H. (2015). Functional isogenic modeling of BRCA1 alleles reveals distinct carrier phenotypes. Oncotarget, 6(28), 25240-25251. https://doi.org/10.18632/oncotarget.4595

Functional isogenic modeling of BRCA1 alleles reveals distinct carrier phenotypes. / Cochran, Rory L.; Cidado, Justin; Kim, Minsoo; Zabransky, Daniel J.; Croessmann, Sarah; Chu, David; Wong, Hong Yuen; Beaver, Julia; Cravero, Karen; Erlanger, Bracha; Parsons, Heather; Heaphy, Christopher M; Meeker, Alan Keith; Lauring, Josh; Park, Ben Ho.

In: Oncotarget, Vol. 6, No. 28, 2015, p. 25240-25251.

Research output: Contribution to journalArticle

Cochran, RL, Cidado, J, Kim, M, Zabransky, DJ, Croessmann, S, Chu, D, Wong, HY, Beaver, J, Cravero, K, Erlanger, B, Parsons, H, Heaphy, CM, Meeker, AK, Lauring, J & Park, BH 2015, 'Functional isogenic modeling of BRCA1 alleles reveals distinct carrier phenotypes', Oncotarget, vol. 6, no. 28, pp. 25240-25251. https://doi.org/10.18632/oncotarget.4595
Cochran RL, Cidado J, Kim M, Zabransky DJ, Croessmann S, Chu D et al. Functional isogenic modeling of BRCA1 alleles reveals distinct carrier phenotypes. Oncotarget. 2015;6(28):25240-25251. https://doi.org/10.18632/oncotarget.4595
Cochran, Rory L. ; Cidado, Justin ; Kim, Minsoo ; Zabransky, Daniel J. ; Croessmann, Sarah ; Chu, David ; Wong, Hong Yuen ; Beaver, Julia ; Cravero, Karen ; Erlanger, Bracha ; Parsons, Heather ; Heaphy, Christopher M ; Meeker, Alan Keith ; Lauring, Josh ; Park, Ben Ho. / Functional isogenic modeling of BRCA1 alleles reveals distinct carrier phenotypes. In: Oncotarget. 2015 ; Vol. 6, No. 28. pp. 25240-25251.
@article{9bcf9b3c11694f3cb72c65fc634552e5,
title = "Functional isogenic modeling of BRCA1 alleles reveals distinct carrier phenotypes",
abstract = "Clinical genetic testing of BRCA1 and BRCA2 is commonly performed to identify specific individuals at risk for breast and ovarian cancers who may benefit from prophylactic therapeutic interventions. Unfortunately, it is evident that deleterious BRCA1 alleles demonstrate variable penetrance and that many BRCA1 variants of unknown significance (VUS) exist. In order to further refine hereditary risks that may be associated with specific BRCA1 alleles, we performed gene targeting to establish an isogenic panel of immortalized human breast epithelial cells harboring eight clinically relevant BRCA1 alleles. Interestingly, BRCA1 mutations and VUS had distinct, quantifiable phenotypes relative to isogenic parental BRCA1 wild type cells and controls. Heterozygous cells with known deleterious BRCA1 mutations (185delAG, C61G and R71G) demonstrated consistent phenotypes in radiation sensitivity and genomic instability assays, but showed variability in other assays. Heterozygous BRCA1 VUS cells also demonstrated assay variability, with some VUS demonstrating phenotypes more consistent with deleterious alleles. Taken together, our data suggest that BRCA1 deleterious mutations and VUS can differ in their range of tested phenotypes, suggesting they might impart varying degrees of risk. These results demonstrate that functional isogenic modeling of BRCA1 alleles could aid in classifying BRCA1 mutations and VUS, and determining BRCA allele cancer risk.",
keywords = "BRCA1, Breast cancer, Centrosome amplification, Haploinsufficiency, VUS",
author = "Cochran, {Rory L.} and Justin Cidado and Minsoo Kim and Zabransky, {Daniel J.} and Sarah Croessmann and David Chu and Wong, {Hong Yuen} and Julia Beaver and Karen Cravero and Bracha Erlanger and Heather Parsons and Heaphy, {Christopher M} and Meeker, {Alan Keith} and Josh Lauring and Park, {Ben Ho}",
year = "2015",
doi = "10.18632/oncotarget.4595",
language = "English (US)",
volume = "6",
pages = "25240--25251",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "28",

}

TY - JOUR

T1 - Functional isogenic modeling of BRCA1 alleles reveals distinct carrier phenotypes

AU - Cochran, Rory L.

AU - Cidado, Justin

AU - Kim, Minsoo

AU - Zabransky, Daniel J.

AU - Croessmann, Sarah

AU - Chu, David

AU - Wong, Hong Yuen

AU - Beaver, Julia

AU - Cravero, Karen

AU - Erlanger, Bracha

AU - Parsons, Heather

AU - Heaphy, Christopher M

AU - Meeker, Alan Keith

AU - Lauring, Josh

AU - Park, Ben Ho

PY - 2015

Y1 - 2015

N2 - Clinical genetic testing of BRCA1 and BRCA2 is commonly performed to identify specific individuals at risk for breast and ovarian cancers who may benefit from prophylactic therapeutic interventions. Unfortunately, it is evident that deleterious BRCA1 alleles demonstrate variable penetrance and that many BRCA1 variants of unknown significance (VUS) exist. In order to further refine hereditary risks that may be associated with specific BRCA1 alleles, we performed gene targeting to establish an isogenic panel of immortalized human breast epithelial cells harboring eight clinically relevant BRCA1 alleles. Interestingly, BRCA1 mutations and VUS had distinct, quantifiable phenotypes relative to isogenic parental BRCA1 wild type cells and controls. Heterozygous cells with known deleterious BRCA1 mutations (185delAG, C61G and R71G) demonstrated consistent phenotypes in radiation sensitivity and genomic instability assays, but showed variability in other assays. Heterozygous BRCA1 VUS cells also demonstrated assay variability, with some VUS demonstrating phenotypes more consistent with deleterious alleles. Taken together, our data suggest that BRCA1 deleterious mutations and VUS can differ in their range of tested phenotypes, suggesting they might impart varying degrees of risk. These results demonstrate that functional isogenic modeling of BRCA1 alleles could aid in classifying BRCA1 mutations and VUS, and determining BRCA allele cancer risk.

AB - Clinical genetic testing of BRCA1 and BRCA2 is commonly performed to identify specific individuals at risk for breast and ovarian cancers who may benefit from prophylactic therapeutic interventions. Unfortunately, it is evident that deleterious BRCA1 alleles demonstrate variable penetrance and that many BRCA1 variants of unknown significance (VUS) exist. In order to further refine hereditary risks that may be associated with specific BRCA1 alleles, we performed gene targeting to establish an isogenic panel of immortalized human breast epithelial cells harboring eight clinically relevant BRCA1 alleles. Interestingly, BRCA1 mutations and VUS had distinct, quantifiable phenotypes relative to isogenic parental BRCA1 wild type cells and controls. Heterozygous cells with known deleterious BRCA1 mutations (185delAG, C61G and R71G) demonstrated consistent phenotypes in radiation sensitivity and genomic instability assays, but showed variability in other assays. Heterozygous BRCA1 VUS cells also demonstrated assay variability, with some VUS demonstrating phenotypes more consistent with deleterious alleles. Taken together, our data suggest that BRCA1 deleterious mutations and VUS can differ in their range of tested phenotypes, suggesting they might impart varying degrees of risk. These results demonstrate that functional isogenic modeling of BRCA1 alleles could aid in classifying BRCA1 mutations and VUS, and determining BRCA allele cancer risk.

KW - BRCA1

KW - Breast cancer

KW - Centrosome amplification

KW - Haploinsufficiency

KW - VUS

UR - http://www.scopus.com/inward/record.url?scp=84944472834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944472834&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.4595

DO - 10.18632/oncotarget.4595

M3 - Article

C2 - 26246475

AN - SCOPUS:84944472834

VL - 6

SP - 25240

EP - 25251

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 28

ER -